Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group

Background and Purpose— In clinical trials and observational studies there is considerable inconsistency in the use of definitions to describe delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage. A major cause for this inconsistency is the combining of radiographic evidence of vasospasm with clinical features of cerebral ischemia, although multiple factors may contribute to DCI. The second issue is the variability and overlap of terms used to describe each phenomenon. This makes comparisons among studies difficult. Methods— An international ad hoc panel of experts involved in subarachnoid hemorrhage research developed and proposed a definition of DCI to be used as an outcome measure in clinical trials and observational studies. We used a consensus-building approach. Results— It is proposed that in observational studies and clinical trials aiming to investigate strategies to prevent DCI, the 2 main outcome measures should be: (1) cerebral infarction identified on CT or MRI or proven at autopsy, after exclusion of procedure-related infarctions; and (2) functional outcome. Secondary outcome measure should be clinical deterioration caused by DCI, after exclusion of other potential causes of clinical deterioration. Vasospasm on angiography or transcranial Doppler can also be used as an outcome measure to investigate proof of concept but should be interpreted in conjunction with DCI or functional outcome. Conclusion— The proposed measures reflect the most relevant morphological and clinical features of DCI without regard to pathogenesis to be used as an outcome measure in clinical trials and observational studies.

[1]  F. Baas,et al.  Plasminogen Activator Inhibitor-1 4G Allele in the 4G/5G Promoter Polymorphism Increases the Occurrence of Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage , 2004, Stroke.

[2]  G. Neil-Dwyer,et al.  Delayed cerebral ischaemia: The pathological substrate , 2005, Acta Neurochirurgica.

[3]  Aman B Patel,et al.  Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association , 1994, Stroke.

[4]  R. Heary,et al.  Persistent Iliac Crest Donor Site Pain: Independent Outcome Assessment , 2002, Neurosurgery.

[5]  J. Torner,et al.  A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. , 1993, Journal of neurosurgery.

[6]  A. Friedman,et al.  Simvastatin Reduces Vasospasm After Aneurysmal Subarachnoid Hemorrhage: Results of a Pilot Randomized Clinical Trial , 2005, Stroke.

[7]  Jan Claassen,et al.  Defining Vasospasm After Subarachnoid Hemorrhage: What Is the Most Clinically Relevant Definition? , 2009, Stroke.

[8]  B. Hindman,et al.  IMPROVING PREDICTION OF OUTCOME IN “GOOD GRADE” SUBARACHNOID HEMORRHAGE , 2007, Neurosurgery.

[9]  R. Grubb,et al.  Autoregulatory Vasodilation of Parenchymal Vessels is Impaired during Cerebral Vasospasm , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  V. Feigin,et al.  Calcium antagonists for aneurysmal subarachnoid haemorrhage. , 2007, The Cochrane database of systematic reviews.

[11]  U. Dirnagl,et al.  Focal laminar cortical MR signal abnormalities after subarachnoid hemorrhage , 2002, Annals of neurology.

[12]  Jan Claassen,et al.  Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage. , 2008, Journal of neurosurgery.

[13]  K. Kanamaru,et al.  Plasma levels of protein C, protein S, and antithrombin III in patients with subarachnoid haemorrhage , 2007, Acta Neurochirurgica.

[14]  J. van Gijn,et al.  Definition of Initial Grading, Specific Events, and Overall Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage: A Survey , 1994, Stroke.

[15]  H. V. Crevel,et al.  Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage , 1986, Neurology.

[16]  S. Mayer,et al.  Sample Size Estimates for Clinical Trials of Vasospasm in Subarachnoid Hemorrhage , 2009, Stroke.

[17]  R. Rosenwasser,et al.  Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report. , 1983, Neurosurgery.

[18]  M. Lauritzen,et al.  Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. , 2006, Brain : a journal of neurology.

[19]  I. C. van der Schaaf,et al.  Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage , 2009, Neuroradiology.

[20]  K. Whang,et al.  Accuracy of transcranial Doppler sonography for predicting cerebral infarction in aneurysmal subarachnoid hemorrhage , 2006, Journal of clinical ultrasound : JCU.

[21]  Ulrich Dirnagl,et al.  Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage , 2009, Brain : a journal of neurology.

[22]  G. Murray,et al.  Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. , 1989, BMJ.

[23]  H. Adams,et al.  Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1994, Stroke.

[24]  Hans-Jakob Steiger,et al.  Intraoperative Detection of Early Microvasospasm in Patients with Subarachnoid Hemorrhage by Using Orthogonal Polarization Spectral Imaging , 2003, Neurosurgery.

[25]  J. Pickard,et al.  Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article. , 2009, Journal of neurosurgery.

[26]  G. Rinkel,et al.  Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. , 2006 .

[27]  H. Steiger,et al.  Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. , 2006, Neurosurgery.

[28]  M. Heinricher,et al.  Brainstem control of cerebral blood flow and application to acute vasospasm following experimental subarachnoid hemorrhage , 2009, Neuroscience.

[29]  W. Alves,et al.  A report of the Cooperative Aneurysm Study , 1995 .

[30]  N. Kassell,et al.  Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study. , 1998, Journal of neurosurgery.

[31]  L. Beenen,et al.  Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in The Netherlands , 2000, Journal of neurology, neurosurgery, and psychiatry.

[32]  G. Teasdale,et al.  A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[33]  A. Algra,et al.  Study Design and Outcome Measures in Studies on Aneurysmal Subarachnoid Hemorrhage , 2002, Stroke.

[34]  A. Rabinstein.  Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1): Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose-Finding Trial , 2009 .

[35]  J. Cervós-Navarro,et al.  Stroke and microcirculation , 1987 .

[36]  H. Lanfermann,et al.  Impairment of Cerebral Perfusion and Infarct Patterns Attributable to Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Prospective MRI and DSA Study , 2007, Stroke.

[37]  M. Raichle,et al.  Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow, and oxygen utilization in humans. , 1977, Journal of neurosurgery.

[38]  P. Box.  CT after subarachnoid hemorrhage: Relation of cerebral perfusion to delayed cerebral ischemia , 2006 .

[39]  H. Lanfermann,et al.  Focal laminar cortical infarcts following aneurysmal subarachnoid haemorrhage , 2007, Neuroradiology.

[40]  B. Tomancok,et al.  Indexed in Embase/excerpta Medica/elsevier Biobase Krause & Pachernegg Gmbh . Verlag Für Medizin Und Wirtschaft . A-3003 Gablitz Online-datenbank Mit Autoren-und Stichwortsuche Aktuell: Reduction of Ischemic Sequelae following Spontaneous Subarachnoid Hemorrhage: a Double-blind, Randomized Compariso , 2022 .

[41]  Jan Claassen,et al.  Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. , 2006, Neurosurgery.

[42]  J. Perry,et al.  Do Statins Improve Outcomes and Reduce the Incidence of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis , 2008, Stroke.

[43]  K. Karnchanapandh.  Effect of increased intracranial pressure on cerebral vasospasm in SAH. , 2008, Acta neurochirurgica. Supplement.

[44]  M. Cowan,et al.  American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.

[45]  S. Juvela,et al.  Early ischemic lesion on computed tomography: predictor of poor outcome among survivors of aneurysmal subarachnoid hemorrhage. , 2007, Journal of neurosurgery.

[46]  H. Yonas,et al.  Radiographic assessment of vasospasm after aneurysmal subarachnoid hemorrhage: the physiological perspective , 2009, Neurological research.

[47]  David M. Rocke,et al.  Effect of Prophylactic Transluminal Balloon Angioplasty on Cerebral Vasospasm and Outcome in Patients With Fisher Grade III Subarachnoid Hemorrhage: Results of a Phase II Multicenter, Randomized, Clinical Trial , 2008, Stroke.

[48]  S. Weigand,et al.  Predictors of Cerebral Infarction in Aneurysmal Subarachnoid Hemorrhage , 2004, Stroke.

[49]  R. Sercombe,et al.  Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. , 2010, Journal of neurosurgery.

[50]  C. Wijmenga,et al.  Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding , 2009, Acta Neurochirurgica.

[51]  I. C. van der Schaaf,et al.  Diagnosing Delayed Cerebral Ischemia With Different CT Modalities in Patients With Subarachnoid Hemorrhage With Clinical Deterioration , 2009, Stroke.

[52]  M. Mlynarek,et al.  Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. , 2002, Journal of neurosurgery.

[53]  M. Mathru.  Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial , 2010 .